The effect of subclinic thyroid pathologies on erythropoietine dose in hemodialysis patients.Published in:Therapeutic Apheresis & Dialysis, 2023, v. 27, n. 3, p. 587, doi. 10.1111/1744-9987.13961By:Onan, Engin;Yasar, Mehmet;Soysal, Busra;Paydas, SaimePublication type:Article